Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Biosimilars: SOP for Vector Design and Cloning – V 2.0

Posted on By


Biosimilars: SOP for Vector Design and Cloning – V 2.0


Standard Operating Procedure for Vector Design and Cloning in Biosimilar Research

Department Biosimilars
SOP No. SOP/BS/003/2025
Supersedes SOP/BS/003/2022
Page No. Page 1 of 14
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To describe the procedure for designing plasmid expression vectors and performing gene cloning required for biosimilar development, ensuring proper integration, regulatory compliance, and traceability of constructs.

2. Scope

This SOP is applicable to R&D personnel in the Biosimilars department who are involved in cloning biosimilar gene constructs into vectors for expression in host cell lines such as CHO, HEK293, or E. coli.

3. Responsibilities

  • Molecular Biology Scientist: Designs vector maps, selects restriction sites, and performs ligation.
  • Research Assistant: Executes the cloning process and confirms insert integration.
  • QA Representative: Verifies and approves cloning results and sequence confirmations.
See also  Biosimilars: SOP for Productivity Testing in Small-Scale Cultures - V 2.0

4. Accountability

The Head of Molecular Biology is accountable for ensuring cloning procedures are conducted as per defined protocols and all documentation is complete and accurate.

5. Procedure

5.1 Vector Backbone Selection

  1. Select suitable plasmid backbone (e.g., pcDNA3.1, pET28a, pCMV6) based on host system and expression requirements.
  2. Confirm:
    • Selectable marker (Ampicillin, Kanamycin, Hygromycin)
    • Promoter compatibility (CMV, T7, EF-1α)
    • Multiple Cloning Site (MCS) availability

5.2 Insert Preparation

  1. Obtain synthesized gene insert or PCR-amplify target gene with designed primers.
  2. Incorporate restriction enzyme recognition sites during primer design (e.g., EcoRI, HindIII).
  3. Purify PCR product using a column purification kit and verify via agarose gel electrophoresis.

5.3 Vector Linearization

  1. Digest the plasmid backbone with appropriate restriction enzymes.
  2. Perform double digestion, if required, to prevent vector re-ligation.
  3. Purify digested vector using gel extraction method.

5.4 Ligation of Insert into Vector

  1. Set up ligation reaction using T4 DNA ligase at the recommended molar ratio (insert:vector = 3:1).
  2. Incubate ligation reaction at 16°C overnight or at room temperature for 2 hours.
See also  Biosimilars: SOP for Agarose Gel Electrophoresis - V 2.0

5.5 Transformation and Colony Screening

  1. Transform ligation mix into competent E. coli DH5α cells.
  2. Plate on antibiotic selection agar plates and incubate overnight at 37°C.
  3. Pick colonies and inoculate into LB broth with appropriate antibiotic.

5.6 Confirmation of Cloning

  1. Extract plasmid DNA using miniprep kit.
  2. Verify insert via:
    • Restriction digestion pattern
    • PCR using gene-specific primers
    • Sanger sequencing for sequence confirmation
  3. Record results in Cloning Verification Report (Annexure-1).

5.7 Storage and Documentation

  1. Store confirmed clones in glycerol stocks at -80°C (Annexure-2: Clone Stock Log).
  2. Archive sequencing results and annotated vector maps in shared database.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • MCS: Multiple Cloning Site
  • CMV: Cytomegalovirus Promoter
  • PCR: Polymerase Chain Reaction
  • QA: Quality Assurance

7. Documents

  1. Cloning Verification Report (Annexure-1)
  2. Clone Stock Log (Annexure-2)
  3. Vector Design Checklist (Annexure-3)
See also  Biosimilars: SOP for ELISA-Based Screening of Clones - V 2.0

8. References

  • ICH Q5B: Expression Construct Analysis Guidelines
  • WHO TRS 978 Annex on Recombinant Technology
  • CDSCO Guidelines on Recombinant Product Development

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Cloning Verification Report

Date Plasmid ID Insert Verified Sequencing Match (%) Status
25/04/2025 pCMV-rhEPO Yes 99.8% Accepted

Annexure-2: Clone Stock Log

Date Clone Name Plasmid ID Storage Temp Stored By
26/04/2025 DH5α-pCMV-rhEPO pCMV-rhEPO -80°C Rajesh Kumar

Annexure-3: Vector Design Checklist

Item Details Checked
Promoter CMV Yes
Selectable Marker Ampicillin Yes
Insert Direction Correct Yes
Sequencing Confirmed Yes Yes

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Updated SOP with sequence verification step and digital record archiving Annual SOP revision
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: BA-BE Studies: SOP for Informed Consent Process Execution – V 2.0
Next Post: Creams: SOP for Validating Mixing Speeds in Cream Manufacturing Equipment – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version